| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |